相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Neuroprotective role of astaxanthin in hippocampal insulin resistance induced by Aβ peptides in animal model of Alzheimer's disease
Syed Obaidur Rahman et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
The Role of Apolipoprotein E Isoforms in Alzheimer's Disease
Alejandro R. Roda et al.
JOURNAL OF ALZHEIMERS DISEASE (2019)
Microglia in Alzheimer's Disease: Exploring How Genetics and Phenotype Influence Risk
Amanda McQuade et al.
JOURNAL OF MOLECULAR BIOLOGY (2019)
Curcumin analogues attenuate Aβ25-35-induced oxidative stress in PC12 cells via Keap1/Nrf2/HO-1 signaling pathways
Jialin Xu et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2019)
The role of astroglia in Alzheimer's disease: pathophysiology and clinical implications
Amaia M. Arranz et al.
LANCET NEUROLOGY (2019)
Molecular mechanisms underlying protective role of quercetin in attenuating Alzheimer's disease
Elizabeta Zaplatic et al.
LIFE SCIENCES (2019)
Assessment of diets containing curcumin, epigallocatechin-3-gallate, docosahexaenoic acid and α-lipoic acid on amyloid load and inflammation in a male transgenic mouse model of Alzheimer's disease: Are combinations more effective?
Matthew J. Sharman et al.
NEUROBIOLOGY OF DISEASE (2019)
Redox regulation by NRF2 in aging and disease
Cody J. Schmidlin et al.
FREE RADICAL BIOLOGY AND MEDICINE (2019)
Ginsenoside Compound K Regulates Amyloid via the Nrf2/Keap1 Signaling Pathway in Mice with Scopolamine Hydrobromide-Induced Memory Impairments
Qing Yang et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2019)
Cerebrosides from Sea Cucumber Improved Aβ1-42-Induced Cognitive Deficiency in a Rat Model of Alzheimer's Disease
Qian Li et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2019)
Therapeutic targeting of the NRF2 and KEAP 1 partnership in chronic diseases
Antonio Cuadrado et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Therapeutic Approaches to Alzheimer's Disease Through Modulation of NRF2
Gahee Bahn et al.
NEUROMOLECULAR MEDICINE (2019)
Natural cholinesterase inhibitors from marine organisms
Lindon W. K. Moodie et al.
NATURAL PRODUCT REPORTS (2019)
Innate immunity in Alzheimer's disease: the relevance of animal models?
Diana K. Franco Bocanegra et al.
JOURNAL OF NEURAL TRANSMISSION (2018)
Resveratrol Attenuates the Cytotoxicity Induced by Amyloid-β1-42 in PC12 Cells by Upregulating Heme Oxygenase-1 via the PI3K/Akt/Nrf2 Pathway
Yang Hui et al.
NEUROCHEMICAL RESEARCH (2018)
Effects of Astaxanthin and Docosahexaenoic-Acid-Acylated Astaxanthin on Alzheimer's Disease in APP/PS1 Double-Transgenic Mice
Hongxia Che et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2018)
Nutritional Intervention to Prevent Alzheimer's Disease: Potential Benefits of Xanthophyll Carotenoids and Omega-3 Fatty Acids Combined
John M. Nolan et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Alzheimer's disease research: the future of BACE inhibitors
Talha Burki
LANCET (2018)
Anti-BACE1 and Antimicrobial Activities of Steroidal Compounds Isolated from Marine Urechis unicinctus
Yong-Zhe Zhu et al.
MARINE DRUGS (2018)
Iridoids and Other Monoterpenes in the Alzheimer's Brain: Recent Development and Future Prospects
Solomon Habtemariam
MOLECULES (2018)
The brain-derived neurotrophic factor in neuronal plasticity and neuroregeneration: new pharmacological concepts for old and new drugs
Solomon Habtemariam
NEURAL REGENERATION RESEARCH (2018)
Apigenin as neuroprotective agent: Of mice and men
Seyed Fazel Nabavi et al.
PHARMACOLOGICAL RESEARCH (2018)
Berberine: Pathways to protect neurons
Xiaorui Lin et al.
PHYTOTHERAPY RESEARCH (2018)
13 reasons why the brain is susceptible to oxidative stress
James Nathan Cobley et al.
REDOX BIOLOGY (2018)
ALZHEIMER DISEASE Rodent models for Alzheimer disease
Juergen Goetz et al.
NATURE REVIEWS NEUROSCIENCE (2018)
Innate immune alterations are elicited in microglial cells before plaque deposition in the Alzheimer's disease mouse model 5xFAD
Antonio Boza-Serrano et al.
SCIENTIFIC REPORTS (2018)
Neuroprotective Effect of Caffeic Acid Phenethyl Ester in A Mouse Model of Alzheimer's Disease Involves Nrf2/HO-1 Pathway
Fabiana Morroni et al.
AGING AND DISEASE (2018)
Docosanoids and elovanoids from omega-3 fatty acids are pro-homeostatic modulators of inflammatory responses, cell damage and neuroprotection
Nicolas G. Bazan
MOLECULAR ASPECTS OF MEDICINE (2018)
Protective effects of omega-3 fatty acids against Alzheimer's disease in rat brain endothelial cells
Lijun Wang et al.
BRAIN AND BEHAVIOR (2018)
Bioavailable curcumin formulations: A review of pharmacokinetic studies in healthy volunteers
Rohitash Jamwal
JOURNAL OF INTEGRATIVE MEDICINE-JIM (2018)
A Recent Update on the Effects of Omega-3 Fatty Acids in Alzheimer's Disease
Thekkuttuparambil Ananthanarayanan Ajith
CURRENT CLINICAL PHARMACOLOGY (2018)
Genetics of β-Amyloid Precursor Protein in Alzheimer's Disease
T. C. W. Julia et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2017)
Plants-Derived Neuroprotective Agents: Cutting the Cycle of Cell Death through Multiple Mechanisms
Taiwo Olayemi Elufioye et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2017)
Resveratrol Ameliorates Tau Hyperphosphorylation at Ser396 Site and Oxidative Damage in Rat Hippocampal Slices Exposed to Vanadate: Implication of ERK1/2 and GSK-3/β Signaling Cascades
Kyoung A. Jhang et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2017)
Protein Phosphorylation is a Key Mechanism in Alzheimer's Disease
Joana Oliveira et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Genome instability in Alzheimer disease
Yujun Hou et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2017)
Protective Effects of Caffeic Acid and the Alzheimer's Brain: An Update
Solomon Habtemariam
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2017)
Therapeutic potential of brain-derived neurotrophic factor (BDNF) and a small molecular mimics of BDNF for traumatic brain injury
Mary Wurzelmann et al.
NEURAL REGENERATION RESEARCH (2017)
Curcumin in Alzheimer's disease: Can we think to new strategies and perspectives for this molecule?
Melania Maria Serafini et al.
PHARMACOLOGICAL RESEARCH (2017)
Monoaminergic neuropathology in Alzheimer's disease
Goran Simic et al.
PROGRESS IN NEUROBIOLOGY (2017)
Stem cell therapy for abrogating stroke-induced neuroinflammation and relevant secondary cell death mechanisms
Connor Stonesifer et al.
PROGRESS IN NEUROBIOLOGY (2017)
Astaxanthin is neuroprotective in an aged mouse model of Parkinson’s disease
Beth Grimmig et al.
Oncotarget (2017)
A phase III randomized trial of gantenerumab in prodromal Alzheimer's disease
Susanne Ostrowitzki et al.
ALZHEIMERS RESEARCH & THERAPY (2017)
Capsaicin reduces Alzheimer-associated tau changes in the hippocampus of type 2 diabetes rats
Weijie Xu et al.
PLOS ONE (2017)
Curcumin Decreases Hyperphosphorylation of Tau by Down-Regulating Caveolin-1/GSK-3β in N2a/APP695swe Cells and APP/PS1 Double Transgenic Alzheimer's Disease Mice
Jieyun Sun et al.
AMERICAN JOURNAL OF CHINESE MEDICINE (2017)
Hyperforin attenuates aluminum-induced Aβ production and Tau phosphorylation via regulating Akt/GSK-3β signaling pathway in PC12 cells
Wanyue Huang et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Docking-based design and synthesis of galantamine-camphane hybrids as inhibitors of acetylcholinesterase
Georgi Stavrakov et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2017)
Long-Term Extensions of Randomized Vaccination Trials of ACC-001 and QS-21 in Mild to Moderate Alzheimer's Disease
Michael Huell et al.
CURRENT ALZHEIMER RESEARCH (2017)
Effect of metal chelators on the aggregation of beta-amyloid peptides in the presence of copper and iron
Foozhan Tahmasebinia et al.
BIOMETALS (2017)
Synthesis, anticholinesterase activity and molecular modeling study of novel carbamate-substituted thymol/carvacrol derivatives
Belma Zengin Kurt et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2017)
Neuroprotective Effects of Citrus Fruit-Derived Flavonoids, Nobiletin and Tangeretin in Alzheimer's and Parkinson's Disease
Nady Braidy et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2017)
Free Superoxide is an Intermediate in the Production of H2O2 by Copper(I)-A Peptide and O2
Karine Reybier et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2016)
Rutin as a Natural Therapy for Alzheimer's Disease: Insights into its Mechanisms of Action
Solomon Habtemariam
CURRENT MEDICINAL CHEMISTRY (2016)
Neuroprotective Effects of Fisetin in Alzheimer's and Parkinson's Diseases: From Chemistry to Medicine
Seyed Fazel Nabavi et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2016)
The Therapeutic Potential of Rosemary (Rosmarinus officinalis) Diterpenes for Alzheimer's Disease
Solomon Habtemariam
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2016)
Modeling complement-driven diseases in transgenic mice: Values and limitations
Yoshiyasu Ueda et al.
IMMUNOBIOLOGY (2016)
Two Phase 2 Multiple Ascending-Dose Studies of Vanutide Cridificar (ACC-001) and QS-21 Adjuvant in Mild-to-Moderate Alzheimer's Disease
Florence Pasquier et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial
Serge Gauthier et al.
LANCET (2016)
Synthesis and evaluation of berberine derivatives and analogs as potential antiacetylcholinesterase and antioxidant agents
Mariagrazia Roselli et al.
PHYTOCHEMISTRY LETTERS (2016)
THE SEROTONERGIC SYSTEM AND COGNITIVE FUNCTION
Dubravka Svob Strac et al.
TRANSLATIONAL NEUROSCIENCE (2016)
Treatment Options in Alzheimer's Disease: The GABA Story
Maite Solas et al.
CURRENT PHARMACEUTICAL DESIGN (2015)
Neuroprotective Effects of Ginkgolide B Against Ischemic Stroke: A Review of Current Literature
Seyed Mohammad Nabavi et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2015)
Bioavailability of dietary polyphenols: Factors contributing to their clinical application in CNS diseases
M. D. Pandareesh et al.
NEUROCHEMISTRY INTERNATIONAL (2015)
Neuroprotective effects of chrysin: From chemistry to medicine
Seyed Fazel Nabavi et al.
NEUROCHEMISTRY INTERNATIONAL (2015)
Ginsenoside Rd and ischemic stroke; a short review of literatures
Seyed Fazel Nabavi et al.
JOURNAL OF GINSENG RESEARCH (2015)
Assessment of anti-amyloidogenic activity of marine red alga G. acerosa against Alzheimer's beta-amyloid peptide 25-35
Arif Nisha Syad et al.
NEUROLOGICAL RESEARCH (2015)
A Phase II Trial of Tideglusib in Alzheimer's Disease
Simon Lovestone et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
Extrasynaptic NMDA Receptor Involvement in Central Nervous System Disorders
Matthew P. Parsons et al.
NEURON (2014)
Use of a new water-soluble Zn sensor to determine Zn affinity for the amyloid-β peptide and relevant mutants
Sabrina Noel et al.
METALLOMICS (2014)
Cellular prion protein and NMDA receptor modulation: protecting against excitotoxicity
Stefanie A. G. Black et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2014)
Levels of Soluble Apolipoprotein E/Amyloid-β (Aβ) Complex Are Reduced and Oligomeric Aβ Increased with APOE4 and Alzheimer Disease in a Transgenic Mouse Model and Human Samples
Leon M. Tai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Structural characterization of Cu2+, Ni2+ and Zn2+ binding sites of model peptides associated with neurodegenerative diseases
Caterina Migliorini et al.
COORDINATION CHEMISTRY REVIEWS (2012)
Affinity of copper and zinc ions to proteins and peptides related to neurodegenerative conditions (Aβ, APP, α-synuclein, PrP)
Izabela Zawisza et al.
COORDINATION CHEMISTRY REVIEWS (2012)
Comparison of polarization properties of human adult microglia and blood-derived macrophages
Bryce A. Durafourt et al.
GLIA (2012)
The role of metallobiology and amyloid-ss peptides in Alzheimer's disease
Blaine R. Roberts et al.
JOURNAL OF NEUROCHEMISTRY (2012)
The Neuropsychological Profile of Alzheimer Disease
Sandra Weintraub et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
Lack of Evidence for the Efficacy of Memantine in Mild Alzheimer Disease
Lon S. Schneider et al.
ARCHIVES OF NEUROLOGY (2011)
Tacrine Treatment at High Dose Suppresses the Recognition Memory in Juvenile and Adult Mice with Attention to Hepatotoxicity
Si-Yuan Pan et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2011)
Iron(II) Binding to Amyloid-β, the Alzheimer's Peptide
Fatima Bousejra-ElGarah et al.
INORGANIC CHEMISTRY (2011)
Iron Promotes the Toxicity of Amyloid β Peptide by Impeding Its Ordered Aggregation
Beinan Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
SOD1 (Copper/Zinc Superoxide Dismutase) Deficiency Drives Amyloid β Protein Oligomerization and Memory Loss in Mouse Model of Alzheimer Disease
Kazuma Murakami et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Increased brain iron coincides with early plaque formation in a mouse model of Alzheimer's disease
Andreana C. Leskovjan et al.
NEUROIMAGE (2011)
Neuropathological Alterations in Alzheimer Disease
Alberto Serrano-Pozo et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2011)
Modulation of GSK-3 as a therapeutic strategy on tau pathologies
Miguel Medina et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2011)
Mitochondrial dysfunction is a trigger of Alzheimer's disease pathophysiology
Paula I. Moreira et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2010)
EFFECT OF TRANSITION METALS IN SYNAPTIC DAMAGE INDUCED BY AMYLOID BETA PEPTIDE
R. M. Uranga et al.
NEUROSCIENCE (2010)
The validity of scopolamine as a pharmacological model for cognitive impairment: A review of animal behavioral studies
Inge Klinkenberg et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2010)
Glutamate receptors, neurotoxicity and neurodegeneration
Anthony Lau et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2010)
A selective TrkB agonist with potent neurotrophic activities by 7,8-dihydroxyflavone
Sung-Wuk Jang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Biological metals and Alzheimer's disease: Implications for therapeutics and diagnostics
James A. Duce et al.
PROGRESS IN NEUROBIOLOGY (2010)
A Role for Synaptic Zinc in Activity-Dependent Aβ Oligomer Formation and Accumulation at Excitatory Synapses
Atul Deshpande et al.
JOURNAL OF NEUROSCIENCE (2009)
Increasing Cu bioavailability inhibits Aβ oligomers and tau phosphorylation
Peter J. Crouch et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Peripheral levels of glutathione and protein oxidation as markers in the development of Alzheimer's disease from Mild Cognitive Impairment
Paloma Bermejo et al.
FREE RADICAL RESEARCH (2008)
Microglial dysfunction and defective β-amyloid clearance pathways in aging Alzheimer's disease mice
Suzanne E. Hickman et al.
JOURNAL OF NEUROSCIENCE (2008)
Microglia derived from aging mice exhibit an altered inflammatory profile
Amanda Sierra et al.
GLIA (2007)
Neurotransmitter deficits in behavioural and psychological symptoms of Alzheimer's disease
A Lanari et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2006)
Microglial senescence: does the brain's immune system have an expiration date?
Wolfgang J. Streit
TRENDS IN NEUROSCIENCES (2006)
Inflammatory cytokine levels correlate with amyloid load in transgenic mouse models of Alzheimer's disease
Nikunj S. Patel et al.
JOURNAL OF NEUROINFLAMMATION (2005)
Curcumin has potent anti-amyloidogenic effects for Alzheimer's β-amyloid fibrils in vitro
K Ono et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2004)
Anti-amyloidogenic activity of tannic acid and its activity to destabilize Alzheimer's β-amyloid fibrils in vitro
K Ono et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2004)
Pharmacological profiles of peptide drug candidates for the treatment of Alzheimer's disease
C Adessi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Memantine in moderate-to-severe Alzheimer's disease
B Reisberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Cholinesterases: New roles in brain function and in Alzheimer's disease
E Giacobini
NEUROCHEMICAL RESEARCH (2003)
Acetylcholine modulation of neural systems involved in learning and memory
PE Gold
NEUROBIOLOGY OF LEARNING AND MEMORY (2003)
Chrysamine G and its derivative reduce amyloid β-induced neurotoxicity in mice
K Ishii et al.
NEUROSCIENCE LETTERS (2002)
Design and characterization of a membrane permeable N-methyl amino acid-containing peptide that inhibits Aβ1-40 fibrillogenesis
DJ Gordon et al.
JOURNAL OF PEPTIDE RESEARCH (2002)
Nordihydroguaiaretic acid potently breaks down pre-formed Alzheimer's β-amyloid fibrils in vitro
K Ono et al.
JOURNAL OF NEUROCHEMISTRY (2002)
Evidence of oxidative damage in Alzheimer's disease brain:: central role for amyloid β-peptide
DA Butterfield et al.
TRENDS IN MOLECULAR MEDICINE (2001)
Redox-active iron mediates amyloid-β toxicity
CA Rottkamp et al.
FREE RADICAL BIOLOGY AND MEDICINE (2001)